MARC LUSTGARTEN PANCREATIC CANCER FOUNDATION: Form 990, tax year 2019

View the entire original 990 at ProPublica ↗

Organization
MARC LUSTGARTEN PANCREATIC CANCER FOUNDATION (EIN 31-1611837)
Tax period
2019-07-01 to 2020-06-30
Filed
2021-05-14
IRS object ID
202131349349307183
Schema version
2019v5.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2021-05-14T22:20:46-05:00ReturnTs
Tax Period End2020-06-30TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1KPMG LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1150 W JEFFERSON SUITE 1900AddressLine1Txt
CityDETROITCityNm
State AbbreviationMIStateAbbreviationCd
ZIP482264429ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2019-07-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN311611837EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1MARC LUSTGARTEN PANCREATIC CANCER FOUNDATIONBusinessNameLine1Txt
FieldValueIRS element (for citing)
In Care Of% JOHANNA RICHMANInCareOfNm
Business Name ControlMARCBusinessNameControlTxt
Phone5167371550PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1415 CROSSWAYS PARK DRIVE Suite SUITAddressLine1Txt
CityWOODBURYCityNm
State AbbreviationNYStateAbbreviationCd
ZIP11797ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonKERRI KAPLANPersonNm
Person TitlePRESIDENT AND CEOPersonTitleTxt
Phone5167371550PhoneNum
Signature2021-05-13SignatureDt
Discuss With Paid PreparerYes (true)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonNICOLE A FITZMAURICEPreparerPersonNm
PTINP10491005PTIN
Phone3132303340PhoneNum
Preparation2021-05-13PreparationDt
FieldValueIRS element (for citing)
Tax2019TaxYr
Build TS2022-09-23 18:48:47ZBuildTS

Form 990 IRS990

Doing Business As Name DoingBusinessAsName

FieldValueIRS element (for citing)
Business Name Line1CURE PANCREATIC CANCER LUSTGARTEN FOBusinessNameLine1Txt
FieldValueIRS element (for citing)
Principal OfficerKERRI KAPLANPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1415 CROSSWAYS PARK DR SUITE DAddressLine1Txt
CityWOODBURYCityNm
State AbbreviationNYStateAbbreviationCd
ZIP11797ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$15,683,239GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.LUSTGARTEN.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1998FormationYr
Legal Domicile StateNYLegalDomicileStateCd
Activity Or MissionTHE LUSTGARTEN FOUNDATION IS THE LARGEST PRIVATE FUNDER OF PANCREATIC CANCER RESEARCH IN THE WORLD. SEE SCHEDULE O.ActivityOrMissionDesc
Voting Members Governing Body16VotingMembersGoverningBodyCnt
Voting Members Independent15VotingMembersIndependentCnt
Total Employee22TotalEmployeeCnt
Total Volunteers1250TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$15,969,356PYContributionsGrantsAmt
CY Contributions Grants$13,046,433CYContributionsGrantsAmt
PY Program Service Revenue$0PYProgramServiceRevenueAmt
CY Program Service Revenue$0CYProgramServiceRevenueAmt
PY Investment Income$13,476,570PYInvestmentIncomeAmt
CY Investment Income$2,409,428CYInvestmentIncomeAmt
PY Other Revenue$54,237PYOtherRevenueAmt
CY Other Revenue-$489,227CYOtherRevenueAmt
PY Total Revenue$29,500,163PYTotalRevenueAmt
CY Total Revenue$14,966,634CYTotalRevenueAmt
PY Grants And Similar Paid$23,777,570PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$18,894,873CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$2,669,280PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$2,890,871CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$156,500PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$385,093CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$2,249,069CYTotalFundraisingExpenseAmt
PY Other Expenses$2,932,376PYOtherExpensesAmt
CY Other Expenses$2,691,944CYOtherExpensesAmt
PY Total Expenses$29,535,726PYTotalExpensesAmt
CY Total Expenses$24,862,781CYTotalExpensesAmt
PY Revenues Less Expenses-$35,563PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$9,896,147CYRevenuesLessExpensesAmt
Total Assets BOY$99,323,748TotalAssetsBOYAmt
Total Assets EOY$90,551,380TotalAssetsEOYAmt
Total Liabilities BOY$8,734,193TotalLiabilitiesBOYAmt
Total Liabilities EOY$9,811,073TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$90,589,555NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$80,740,307NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTHE LUSTGARTEN FOUNDATION IS THE LARGEST PRIVATE FUNDER OF PANCREATIC CANCER RESEARCH IN THE WORLD. SEE SCHEDULE O.MissionDesc
Significant New Program SrvcfalseSignificantNewProgramSrvcInd
Significant ChangefalseSignificantChangeInd
Expense$19,760,631ExpenseAmt
Grant$18,894,873GrantAmt
DescRESEARCH PROGRAM: THE FOUNDATION COMMITTED AN ADDITIONAL $18.9 MILLION TO RESEARCH DURING FY2020, BRINGING THE CUMULATIVE TOTAL INVESTED THROUGH JUNE 2020 TO $206 MILLION. SEE SCHEDULE O.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$1,165,750ExpenseAmt
DescPUBLIC EDUCATION AND INFORMATION PROGRAM: THE LUSTGARTEN FOUNDATION CREATED, PRINTED AND DISTRIBUTED MATERIALS TO UPDATE PATIENTS, CAREGIVERS, SURVIVORS, DONORS, VOLUNTEERS, WALK AND EVENT LEADERS AND CORPORATE SPONSORS WITH NEWS ABOUT OUR RESEARCH PROGRAM AND FOUNDATION MILESTONES. ADDITIONALLY, THE FOUNDATION SHARES INFORMATION WITH CONSTITUENTS AT MANY FORUMS THROUGHOUT THE YEAR. SEE SCHEDULE O.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$246,644ExpenseAmt
DescPROFESSIONAL EDUCATION PROGRAM: PROFESSIONAL EDUCATION CONSISTED OF ORGANIZING AN ANNUAL SCIENTIFIC CONFERENCES FOR GRANTEES AND LEADERS IN THE FIELD TO PRESENT AND SHARE INFORMATION, CONDUCTING HIGH-LEVEL MEETINGS WITH SCIENTISTS, DIRECTORS OF OUR FIVE DEDICATED LABORATORIES AND COLLABORATING ORGANIZATIONS, AS WELL AS ATTENDING/PRESENTING AT SCIENTIFIC MEETINGS FOR ORGANIZATIONS INCLUDING THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AND STAND UP TO CANCER. SEE SCHEDULE O.Desc
FieldValueIRS element (for citing)
Total Program Service Expenses$21,173,025TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredYes (true)ScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesfalseLobbyingActivitiesInd
Subject To Proxy TaxfalseSubjectToProxyTaxInd
Donor Advised FundfalseDonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtfalseCollectionsOfArtInd
Credit CounselingfalseCreditCounselingInd
Donor Rstr Or Quasi EndowmentsfalseDonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecfalseReportInvestmentsOtherSecInd
Report Program Related InvstfalseReportProgramRelatedInvstInd
Report Other AssetsfalseReportOtherAssetsInd
Report Other LiabilitiesYes (true)ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (true)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (true)IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtfalseConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficefalseForeignOfficeInd
Foreign ActivitiesfalseForeignActivitiesInd
More Than5000 K To OrgfalseMoreThan5000KToOrgInd
More Than5000 K To IndividualsfalseMoreThan5000KToIndividualsInd
Professional FundraisingYes (true)ProfessionalFundraisingInd
Fundraising ActivitiesYes (true)FundraisingActivitiesInd
Gaming ActivitiesfalseGamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsYes (true)GrantsToOrganizationsInd
Grants To IndividualsfalseGrantsToIndividualsInd
Schedule J RequiredYes (true)ScheduleJRequiredInd
Tax Exempt BondsfalseTaxExemptBondsInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingfalseLoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemfalseBusinessRlnWithFamMemInd
Business Rln With35 Ctrl EntfalseBusinessRlnWith35CtrlEntInd
Deductible Non Cash ContriYes (true)DeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityfalseDisregardedEntityInd
Related EntityfalseRelatedEntityInd
Related Organization Ctrl EntfalseRelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgfalseTrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
IRP Document35IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (true)BackupWthldComplianceInd
Employee22EmployeeCnt
Employment Tax Returns FiledYes (true)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitfalseUnrelatedBusIncmOverLimitInd
Foreign Financial AccountfalseForeignFinancialAccountInd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsfalseNondeductibleContributionsInd
Quid Pro Quo ContributionsYes (true)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (true)QuidProQuoContriDisclInd
Form8282 Property Disposed OffalseForm8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht PymtfalseSubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst IncfalseSubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members16GoverningBodyVotingMembersCnt
Independent Voting Member15IndependentVotingMemberCnt
Family Or Business RlnYes (true)FamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsfalseChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersfalseMembersOrStockholdersInd
Election Of Board MembersfalseElectionOfBoardMembersInd
Decisions Subject To ApprovafalseDecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (true)MinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersfalseLocalChaptersInd
Form990 Provided To Gvrn BodyYes (true)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOYes (true)CompensationProcessCEOInd
Compensation Process OtherfalseCompensationProcessOtherInd
Investment In Joint VenturefalseInvestmentInJointVentureInd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldHIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldUTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonJOHANNA RICHMANPersonNm
Phone5167371555PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1415 CROSSWAYS PARK DRIVE SUITE DAddressLine1Txt
CityWOODBURYCityNm
State AbbreviationNYStateAbbreviationCd
ZIP11797ZIPCd
FieldValueIRS element (for citing)
Info In Schedule O Part VIIYes (X)InfoInScheduleOPartVIIInd

Form990 Part VII Section A Form990PartVIISectionAGrp (19 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmt
ROBERT F VIZZA PHD
CHAIRMAN EMERITUS35.00.0Yes (X)Yes (X)$340,687$0$52,612
KERRI KAPLAN
PRESIDENT & CEO (NON-VOTING)45.00.0Yes (X)Yes (X)$322,661$0$27,515
Catherine Weber
CHIEF OPERATING OFFICER40.00.0Yes (X)$152,734$0$42,364
Jessica DiGiamo Diaz
Dir. of Finance (thru 12/2019)40.00.0Yes (X)$147,081$0$27,515
Andrew Lustgarten
CHAIRMAN5.00.0Yes (X)Yes (X)$0$0$0
JAMES L DOLAN
VICE CHAIRMAN2.00.0Yes (X)Yes (X)$0$0$0
ADAM SILVER
VICE CHAIRMAN2.00.0Yes (X)Yes (X)$0$0$0
CHARLES F DOLAN
CHAIRMAN EMERITUS2.00.0Yes (X)Yes (X)$0$0$0
WILLIAM BELL
TREASURER2.00.0Yes (X)Yes (X)$0$0$0
JOHN H COBB
DIRECTOR2.00.0Yes (X)$0$0$0
JESSICA LUSTGARTEN COURTEMANCHE
DIRECTOR2.00.0Yes (X)$0$0$0
Quentin F Dolan
Trustee2.00.0Yes (X)$0$0$0
JENNIE FORTUNOFF
DIRECTOR2.00.0Yes (X)$0$0$0
KENNETH GOODMAN MD FACR
DIRECTOR2.00.0Yes (X)$0$0$0
MARCIA LUSTGARTEN
DIRECTOR2.00.0Yes (X)$0$0$0
SHIELA MAHONY
DIRECTOR2.00.0Yes (X)$0$0$0
John O'Brien
DIRECTOR2.00.0Yes (X)$0$0$0
Charles R Schueler
DIRECTOR2.00.0Yes (X)$0$0$0
Willa Shalit
DIRECTOR2.00.0Yes (X)$0$0$0
FieldValueIRS element (for citing)
Total Reportable Comp From Org$963,163TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$150,006TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K4IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedfalseFormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (true)TotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmtAddress Line1ContractorAddress/ForeignAddress/AddressLine1TxtCityContractorAddress/ForeignAddress/CityNmProvince Or StateContractorAddress/ForeignAddress/ProvinceOrStateNmCountryContractorAddress/ForeignAddress/CountryCdForeign PostalContractorAddress/ForeignAddress/ForeignPostalCd
Community Counseling Service Co L
PO Box 824885PHILADELPHIAPA191824885Consultants$187,593
WSI Paid Search Ltd
MARKETING$153,800830 DIXON ROADETOBICOKEONTARIOCAM9W 6Y8
MKM Distributors
3330 Dundee N2NORTHBROOKIL60062T-SHIRTS FOR EVENT$149,229
Faircom New York
12 West 27th Street 13TH FL SUITENEW YORKNY10001MARKETING$133,026
Regina Printing
260 Wagner StreetMIDDLESEXNJ08846PRINTING$131,159
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K7CntrctRcvdGreaterThan100KCnt
Fundraising$3,519,808FundraisingAmt
All Other Contributions$9,526,625AllOtherContributionsAmt
Noncash Contributions$121,633NoncashContributionsAmt
Total Contributions$13,046,433TotalContributionsAmt
Total Program Service Revenue$0TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$2,409,428TotalRevenueColumnAmt
Exclusion$2,409,428ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$7,855TotalRevenueColumnAmt
Exclusion$7,855ExclusionAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$219,523FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$3,519,808ContriRptFundraisingEventAmt
Fundraising Direct Expenses$716,605FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column-$497,082TotalRevenueColumnAmt
Exclusion-$497,082ExclusionAmt
FieldValueIRS element (for citing)
Gaming Gross Income$0GamingGrossIncomeAmt
Gaming Direct Expenses$0GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
FieldValueIRS element (for citing)
Gross Sales Of Inventory$0GrossSalesOfInventoryAmt
Cost Of Goods Sold$0CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
FieldValueIRS element (for citing)
Other Revenue Total$0OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$14,966,634TotalRevenueColumnAmt
Exclusion$1,920,201ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$18,894,873TotalAmt
Program Services$18,894,873ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Benefits To Members BenefitsToMembersGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$1,160,038TotalAmt
Program Services$637,295ProgramServicesAmt
Management And General$251,774ManagementAndGeneralAmt
Fundraising$270,969FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$757,715TotalAmt
Program Services$436,528ProgramServicesAmt
Management And General$50,968ManagementAndGeneralAmt
Fundraising$270,219FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$280,685TotalAmt
Program Services$215,652ProgramServicesAmt
Management And General$29,807ManagementAndGeneralAmt
Fundraising$35,226FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$534,755TotalAmt
Program Services$298,774ProgramServicesAmt
Management And General$108,158ManagementAndGeneralAmt
Fundraising$127,823FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$157,678TotalAmt
Program Services$101,702ProgramServicesAmt
Management And General$35,478ManagementAndGeneralAmt
Fundraising$20,498FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$108,790TotalAmt
Management And General$108,790ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$385,093TotalAmt
Fundraising$385,093FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$636,260TotalAmt
Management And General$636,260ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$535,698TotalAmt
Fundraising$535,698FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$350,119TotalAmt
Program Services$130,472ProgramServicesAmt
Management And General$79,601ManagementAndGeneralAmt
Fundraising$140,046FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$251,315TotalAmt
Program Services$110,579ProgramServicesAmt
Management And General$40,210ManagementAndGeneralAmt
Fundraising$100,526FundraisingAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$235,660TotalAmt
Program Services$106,047ProgramServicesAmt
Management And General$35,349ManagementAndGeneralAmt
Fundraising$94,264FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$101,956TotalAmt
Program Services$15,294ProgramServicesAmt
Management And General$20,391ManagementAndGeneralAmt
Fundraising$66,271FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$72,210TotalAmt
Program Services$31,772ProgramServicesAmt
Management And General$11,554ManagementAndGeneralAmt
Fundraising$28,884FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$39,751TotalAmt
Program Services$17,708ProgramServicesAmt
Management And General$6,303ManagementAndGeneralAmt
Fundraising$15,740FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
PUBLIC INFORMATION COSTS$104,331$103,831$500
BANK AND CREDIT CARD FEES$141,994$13,726$128,268
RESEARCH SUPPORT$40,000$40,000
ALL OTHER EXPENSES$73,860$32,498$11,818$29,544

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$24,862,781TotalAmt
Program Services$21,173,025ProgramServicesAmt
Management And General$1,440,687ManagementAndGeneralAmt
Fundraising$2,249,069FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$5,845,815BOYAmt
EOY$1,910,337EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$12,638,779BOYAmt
EOY$318,852EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$231,411BOYAmt
EOY$174,487EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$373,577LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$208,053LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$236,334BOYAmt
EOY$165,524EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$80,371,409BOYAmt
EOY$87,982,180EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$99,323,748BOYAmt
EOY$90,551,380EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$816,700BOYAmt
EOY$478,590EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$7,539,230BOYAmt
EOY$8,774,834EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$312,614BOYAmt
EOY$480,772EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$65,649BOYAmt
EOY$76,877EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$8,734,193BOYAmt
EOY$9,811,073EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$90,533,910BOYAmt
EOY$80,376,307EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$55,645BOYAmt
EOY$364,000EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$90,589,555BOYAmt
EOY$80,740,307EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$99,323,748BOYAmt
EOY$90,551,380EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss-$9,896,147ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$46,899NetUnrlzdGainsLossesInvstAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredfalseFederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$41,900,164CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$43,176,330CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$12,048,978CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$15,969,356CurrentTaxYearMinus1YearAmt
Current Tax Year$13,046,433CurrentTaxYearAmt
Total$126,141,261TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$41,900,164CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$43,176,330CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$12,048,978CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$15,969,356CurrentTaxYearMinus1YearAmt
Current Tax Year$13,046,433CurrentTaxYearAmt
Total$126,141,261TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$55,234,513SubstantialContributorsTotAmt
Public Support Total170$70,906,748PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$907,101CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$1,377,642CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$515,595CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$1,755,392CurrentTaxYearMinus1YearAmt
Current Tax Year$2,417,283CurrentTaxYearAmt
Total$6,973,013TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus3 Years$349,626CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$99,169CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$371,093CurrentTaxYearMinus1YearAmt
Current Tax Year$219,523CurrentTaxYearAmt
Total$1,039,411TotalAmt
FieldValueIRS element (for citing)
Total Support$134,153,685TotalSupportAmt
Public Support CY1700.52855PublicSupportCY170Pct
Public Support PY1700.53625PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Form990 Schedule A Part VI Form990ScheduleAPartVIGrp

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE A, PART IIFormAndLineReferenceDesc
ExplanationTHE FOUNDATION CHANGED ITS FISCAL YEAR END DATE TO JUNE 30TH IN 2018, RESULTING IN A SHORT PERIOD TAX YEAR OF SIX MONTHS FROM JANUARY 1 JUNE 30, 2018. AS A RESULT, AMOUNTS REPORTED IN COLUMN (c) REFLECT AMOUNTS FOR THE SHORT PERIOD JANUARY 1, 2018 - JUNE 30, 2018. COLUMNS (a) and (b) REFLECT AMOUNTS REPORTED FOR CALENDAR YEARS 2016 - 2017, RESPECTIVELY. AMOUNTS ON LINE 10 REPRESENT GROSS INCOME FROM FUNDRAISING EVENTS.ExplanationTxt

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

FieldValueIRS element (for citing)
Art Public Exhibition AmountsArtPublicExhibitionAmountsGrp
Held Works ArtHeldWorksArtGrp
CY Minus3 Yr Endwmt FundCYMinus3YrEndwmtFundGrp
CY Minus4 Yr Endwmt FundCYMinus4YrEndwmtFundGrp
LandLandGrp
BuildingsBuildingsGrp

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$5,865OtherCostOrOtherBasisAmt
Depreciation$872DepreciationAmt
Book Value$4,993BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$10,705OtherCostOrOtherBasisAmt
Depreciation$4,119DepreciationAmt
Book Value$6,586BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$357,007OtherCostOrOtherBasisAmt
Depreciation$203,062DepreciationAmt
Book Value$153,945BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$165,524TotalBookValueLandBuildingsAmt
Federal Income Tax Liability$0FederalIncomeTaxLiabilityAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

FieldValueIRS element (for citing)
DescDEFERRED RENT OBLIGATIONDesc
Amt$76,877Amt
FieldValueIRS element (for citing)
Total Liability$76,877TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$18,820,491TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst$46,899NetUnrealizedGainsInvstAmt
Donated Services And Use Fclts$3,946,136DonatedServicesAndUseFcltsAmt
Revenue Not Reported$3,993,035RevenueNotReportedAmt
Revenue Subtotal$14,827,456RevenueSubtotalAmt
Investment Expenses Not Incld$636,260InvestmentExpensesNotIncldAmt
Other Revenues Not Included-$497,082OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt$139,178RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$14,966,634TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$28,669,739TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts$3,946,136DonatedServicesUseFcltsAmt
Other Expenses Included$497,082OtherExpensesIncludedAmt
Expenses Not Reported$4,443,218ExpensesNotReportedAmt
Expenses Subtotal$24,226,521ExpensesSubtotalAmt
Investment Expenses Not Incld2$636,260InvestmentExpensesNotIncld2Amt
Expenses Not Rpt Fincl Stmt$636,260ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$24,862,781TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
SCHEDULE D, PART X, LINE 2:THE FOUNDATION HAS RECEIVED A FINAL DETERMINATION LETTER FROM THE INTERNAL REVENUE SERVICE STATING THAT THE FOUNDATION IS EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3). THE FOUNDATION IS TREATED AS A PUBLIC CHARITY AS DEFINED IN SECTIONS 509(A)(1) AND 170(B)(1)(A)(VI). The Foundation follows the provisions of Accounting Standards Codification (ASC) Subtopic 740-10, Income Taxes Overall (ASC 740-10), relating to uncertainty in income taxes. For the Foundation, ASC 740-10 is primarily applicable to the incurrence of unrelated business income tax attributable to certain of its investments. ASC 740-10 establishes a minimum threshold for financial statement recognition of the benefits of positions taken, or expected to be taken, in filing tax returns. It requires the evaluation of tax positions taken or expected to be taken, in the course of preparing the Foundations income tax returns to determine whether the tax positions are "more likely than not" of being sustained by the applicable tax authority. Tax positions not deemed to meet the more-likely than-not threshold are recorded as tax expense. For the years ended June 30, 2020 and 2019, the Foundation has not identified or provided for any such positions.
PART XI, LINE 4B - OTHER ADJUSTMENTS:DIRECT FUNDRAISING EXPENSES $ (716,605) DIRECT BENEFITS 219,523 ------------ TOTAL TO SCHEDULE D, PART XI, LINE 4B $ (497,082) PART XII, LINE 2D - OTHER ADJUSTMENTS: DIRECT FUNDRAISING EXPENSES $ 716,605 DIRECT BENEFITS (219,523) ------------ TOTAL TO SCHEDULE D, PART XII LINE 2D $ 497,082

Schedule G IRS990ScheduleG

FieldValueIRS element (for citing)
Mail SolicitationsYes (X)MailSolicitationsInd
Email SolicitationsYes (X)EmailSolicitationsInd
In Person SolicitationsYes (X)InPersonSolicitationsInd
Solicitation Of Non Govt GrantsYes (X)SolicitationOfNonGovtGrantsInd
Special Fundraising EventsYes (X)SpecialFundraisingEventsInd
Agrmt Prof Fundraising ActyYes (true)AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp

FieldValueIRS element (for citing)
PersonFaircom New YorkPersonNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line112 WEST 27TH STREETAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10001ZIPCd
FieldValueIRS element (for citing)
ActivityDIRECT MAIL & MARKETINGActivityTxt
Fundraiser Control Of FundsfalseFundraiserControlOfFundsInd
Gross Receipts$1,570,165GrossReceiptsAmt
Retained By Contractor$385,093RetainedByContractorAmt
Net To Organization$1,185,072NetToOrganizationAmt
FieldValueIRS element (for citing)
Total Gross Receipts$1,570,165TotalGrossReceiptsAmt
Total Retained By Contractors$385,093TotalRetainedByContractorsAmt
Total Net To Organization$1,185,072TotalNetToOrganizationAmt
Licensed StatesALLicensedStatesCd
Licensed StatesARLicensedStatesCd
Licensed StatesCALicensedStatesCd
Licensed StatesCOLicensedStatesCd
Licensed StatesCTLicensedStatesCd
Licensed StatesFLLicensedStatesCd
Licensed StatesGALicensedStatesCd
Licensed StatesHILicensedStatesCd
Licensed StatesILLicensedStatesCd
Licensed StatesKSLicensedStatesCd
Licensed StatesKYLicensedStatesCd
Licensed StatesMELicensedStatesCd
Licensed StatesMDLicensedStatesCd
Licensed StatesMALicensedStatesCd
Licensed StatesMILicensedStatesCd
Licensed StatesMNLicensedStatesCd
Licensed StatesMOLicensedStatesCd
Licensed StatesNVLicensedStatesCd
Licensed StatesNHLicensedStatesCd
Licensed StatesNJLicensedStatesCd
Licensed StatesNMLicensedStatesCd
Licensed StatesNYLicensedStatesCd
Licensed StatesNCLicensedStatesCd
Licensed StatesOHLicensedStatesCd
Licensed StatesOKLicensedStatesCd
Licensed StatesORLicensedStatesCd
Licensed StatesPALicensedStatesCd
Licensed StatesSCLicensedStatesCd
Licensed StatesTNLicensedStatesCd
Licensed StatesUTLicensedStatesCd
Licensed StatesVALicensedStatesCd
Licensed StatesWALicensedStatesCd
Licensed StatesWVLicensedStatesCd
Licensed StatesWILicensedStatesCd

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1BASHEvent1Nm
Gross Receipts Event1$994,755GrossReceiptsEvent1Amt
Charitable Contri Event1$889,384CharitableContriEvent1Amt
Gross Revenue Event1$105,371GrossRevenueEvent1Amt
Food And Beverage Event1$172,062FoodAndBeverageEvent1Amt
Other Direct Expenses Event1$85,348OtherDirectExpensesEvent1Amt
Event2LONG ISLD WALKEvent2Nm
Gross Receipts Event2$872,915GrossReceiptsEvent2Amt
Charitable Contri Event2$857,549CharitableContriEvent2Amt
Gross Revenue Event2$15,366GrossRevenueEvent2Amt
Rent Facility Costs Event2$59,139RentFacilityCostsEvent2Amt
Food And Beverage Event2$5,712FoodAndBeverageEvent2Amt
Other Direct Expenses Event2$82,326OtherDirectExpensesEvent2Amt
Other Events Total1OtherEventsTotalCnt
Gross Receipts Other Events$1,871,661GrossReceiptsOtherEventsAmt
Charitable Contri Other Events$1,772,875CharitableContriOtherEventsAmt
Gross Revenue Other Events$98,786GrossRevenueOtherEventsAmt
Rent Fclty Costs Other Events$60,336RentFcltyCostsOtherEventsAmt
Food And Beverage Other Events$95,416FoodAndBeverageOtherEventsAmt
Oth Direct Expnss Other Events$156,266OthDirectExpnssOtherEventsAmt
Gross Receipts Total$3,739,331GrossReceiptsTotalAmt
Charitable Contributions Tot$3,519,808CharitableContributionsTotAmt
Gross Revenue Total Events$219,523GrossRevenueTotalEventsAmt
Rent Fclty Costs Total Events$119,475RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events$273,190FoodAndBeverageTotalEventsAmt
Oth Direct Expnss Total Events$323,940OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$716,605DirectExpenseSummaryEventsAmt
Net Income Summary-$497,082NetIncomeSummaryAmt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE G, PART I, LINE 2B, COLUMN (V)FormAndLineReferenceDesc
ExplanationFAIRCOM NEW YORK - DESIGN SERVICES, $165,936; DIRECT MAIL, $94,200; POSTAGE AND SHIPPING, $65,107; PRINTING, $56,250; MARKETING, $3,600. PER AGREEMENT, PROFESSIONAL FEES FOR 8 CAMPAIGNS IN FY-2020 WAS $385,093.ExplanationTxt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Recipient Table RecipientTable (11 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxt
STAND UP TO CANCER - ENTERTAINMENT IND FDN
10880 Wilshire BLvdLos AngelesCA90024951644609501(c)(3)$8,389,579Pancreatic Cancer Research
Johns Hopkins University
1650 Orleans StreetBaltimoreMD21287520595110501(c)(3)$4,573,733Pancreatic Cancer Research
Cold Spring Harbor Laboratory
One Bungtown RdCold Spring HBRNY11724112013303501(c)(3)$2,190,093Pancreatic Cancer Research
Massachusetts Institute of Technology
77 Massachusetts AvenueCambridgeMA02139042103594501(c)(3)$1,173,816Pancreatic Cancer Research
Dana Farber Cancer Institute
450 Brookline AvenueNEW YORKNY02215042263040501(c)(3)$875,381Pancreatic Cancer Research
The Trustees of Columbia Univ in the City of NY
615 W 13th St MC 8741New YorkNY10027135598093501(c)(3)$421,734Pancreatic Cancer Research
Memorial Sloan-Kettering Cancer Center
633 Third AvenueNEW YORKNY10017131924236501(c)(3)$324,537Pancreatic Cancer Research
Children's Hospital Corporation
300 Longwood AvenueBOSTONMA02115042774441501(c)(3)$302,000Pancreatic Cancer Research
The Salk Institute For Biological Studies
10010 N Torrey Pines RdLA JOLLACA92037952160097501(c)(3)$302,000Pancreatic Cancer Research
Whitehead Institute for Biomedical Research
9 Cambridge CenterCAMBRIDGEMA02142061043412501(c)(3)$302,000Pancreatic Cancer Research
American Association for Cancer Research
615 Chestnut StPHILADELPHIAPA191064404236251648501(c)(3)$35,000Pancreatic Cancer Research
FieldValueIRS element (for citing)
Total501c3 Org11Total501c3OrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE I, PART I, LINE 2FormAndLineReferenceDesc
ExplanationTHE FOUNDATION MAKES GRANTS TO 501(C)(3) PUBLIC CHARITIES CONDUCTING PANCREATIC CANCER RESEARCH. AS PART OF THE REQUIREMENT FOR RECEIVING SUCH GRANTS, THE FOUNDATION REQUIRES PERIODIC UPDATES AND REPORTING ON SCIENTIFIC PROGRESS AND FINANCIAL EXPENDITURES.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentfalseSeverancePaymentInd
Supplemental Nonqual Rtr PlanfalseSupplementalNonqualRtrPlanInd
Equity Based Comp ArrngmfalseEquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgfalseCompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related OrgsfalseCompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgfalseCompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsfalseCompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsYes (true)AnyNonFixedPaymentsInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (4 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
ROBERT F VIZZA PHD
CHAIRMAN EMERITUS$302,552$0$38,135$0$0$0$29,708$0$22,904$0$393,299$0$0$0
KERRI KAPLAN
PRESIDENT & CEO (NON-VOTING)$257,172$0$65,489$0$0$0$0$0$27,515$0$350,176$0$0$0
Jessica DiGiamo Diaz
Dir. of Finance (thru 12/2019)$135,780$0$11,301$0$0$0$0$0$27,515$0$174,596$0$0$0
Catherine Weber
CHIEF OPERATING OFFICER$130,000$0$18,969$0$3,765$0$19,460$0$22,904$0$195,098$0$0$0

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceNONFIXED PAYMENTSFormAndLineReferenceDesc
ExplanationSCHEDULE J, PART I, LINE 7 IN 2019, OFFICERS AND EMPLOYEES RECEIVED NONFIXED DISCRETIONARY BONUSES AS REPORTED ON SCHEDULE J, PART II, COLUMN (B) (II).ExplanationTxt

Schedule M IRS990ScheduleM

FieldValueIRS element (for citing)
Works Of ArtWorksOfArtGrp
Art Historical TreasuresArtHistoricalTreasuresGrp
Art Fractional InterestArtFractionalInterestGrp
Books And PublicationsBooksAndPublicationsGrp
Clothing And Household GoodsClothingAndHouseholdGoodsGrp
Cars And Other VehiclesCarsAndOtherVehiclesGrp
Boats And PlanesBoatsAndPlanesGrp
Intellectual PropertyIntellectualPropertyGrp

Securities Publicly Traded SecuritiesPubliclyTradedGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution27ContributionCnt
Noncash Contributions Rpt F990$121,633NoncashContributionsRptF990Amt
Method Of Determining RevenuesAverage Market ValueMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Securities Closely Held StockSecuritiesCloselyHeldStockGrp
Secur Prtnrshp Trust IntrstsSecurPrtnrshpTrustIntrstsGrp
Securities MiscellaneousSecuritiesMiscellaneousGrp
Qualified Contrib Hist StructQualifiedContribHistStructGrp
Qualified Contrib OtherQualifiedContribOtherGrp
Real Estate ResidentialRealEstateResidentialGrp
Real Estate CommercialRealEstateCommercialGrp
Real Estate OtherRealEstateOtherGrp
CollectiblesCollectiblesGrp
Food InventoryFoodInventoryGrp
Drugs And Medical SuppliesDrugsAndMedicalSuppliesGrp
TaxidermyTaxidermyGrp
Historical ArtifactsHistoricalArtifactsGrp
Scientific SpecimensScientificSpecimensGrp
Archaeological ArtifactsArchaeologicalArtifactsGrp
Any Property That Must Be HeldfalseAnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (true)ReviewProcessUnusualNCGiftsInd
Third Parties UsedfalseThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE M, PART I, COLUMN (B)FormAndLineReferenceDesc
ExplanationTHE AMOUNT IN COLUMN (B) REPRESENTS THE NUMBER OF CONTRIBUTIONS.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (7 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART I, LINE 1The Lustgarten Foundation is the largest private funder of pancreatic cancer research in the world. The Foundations mission is to cure pancreatic cancer by funding scientific and clinical research related to the diagnosis, treatment and prevention of pancreatic cancer; providing research information and clinical support services to patients, caregivers and individuals at high risk; and increasing public awareness and hope for those dealing with this disease. Since its inception, the Lustgarten Foundation has directed more than $200 million to research and has assembled the best scientific minds with the hope that one day, a cure can be found. FORM 990, PART III, LINE 1 The Foundations mission is to cure pancreatic cancer by funding scientific and clinical research related to the diagnosis, treatment and prevention of pancreatic cancer; providing research information and clinical support services to patients, caregivers and individuals at high risk; and increasing public awareness and hope for those dealing with this disease.
FORM 990, PART III, LINE 4ARESEARCH PROGRAM $19,760,631 GRANTS $18,894,873 The Foundations mission is to cure pancreatic cancer. To advance progress toward this goal, the Foundation committed an additional $18.9 million to research during FY2020, bringing the cumulative total invested through June 2020 to $206 million. Through this significant investment in research, the Foundation has supported more than 300 projects worldwide, with partnerships at nearly 70 academic institutions. Additionally, the Foundation provides two-thirds of the worlds private funding for pancreatic cancer research from organizations focused solely on this disease. During FY2020, major Lustgarten-funded research milestones and achievements have focused on: Stretching the Boundaries of Science Through Clinical Trials: The Foundation established the Clinical Accelerator Initiative (CAI) to shorten the time from clinical trial concept to launch using a Lustgarten-developed process based on the best available science and employing cutting-edge biomarkers. These "smarter" clinical trials will generate large volumes of data that scientists can use now and in the future to inform and improve clinical trials and expedite new treatments. The newly formed Translational Advisory Group, led by Chief Medical Advisor Dr. Elizabeth Jaffee and comprised of renowned pancreatic cancer experts, guides the CAI by identifying, reviewing and developing the best translational projects to impact patient care in the clinic. The Translational Advisory Group is building a network of sites to execute the proposed research in small clinical trials of 10-20 patients each. These science-driven studies could dramatically inform research, enabling investigators to quickly determine if patients are responding to specific treatment approaches and why information that will help enhance clinical trials and ultimately, clinical care. In FY2020, the Lustgarten Foundation also laid the groundwork for the first two trials to be conducted through the CAI. These trials are focused on improving treatments and outcomes for patients with late-state pancreatic cancer: - Trial 1: PASS-01 (Pancreatic Adenocarcinoma Signature Stratification for treatment): Researchers are working to maximize the response to standard, first-line chemotherapy and to improve patient outcomes by comparing two standard-of-care chemotherapy regimens (Gemcitabine and Abraxane, and modified FOLFIRINOX). For each trial participant, researchers develop an organoid a 3D cell culture of a patients specific tumor and analyze its genetics, biology and drug sensitivity to determine the most effective chemotherapy regimen for each patient. If successful, this trial can pave the way for the use of organoids to personalize therapies for metastatic pancreatic cancer patients. - Trial 2: Phase 2 Study of Plerixafor and Cemiplimab in Metastatic Pancreatic Cancer: Researchers are focusing on combinations of drugs that may overcome the barriers limiting the effectiveness of immunotherapy treatments in pancreatic cancer. This trial is testing previous research suggesting treatment with a stem-cell mobilizer (Plerixafor) in combination with a PD-L1 inhibitor (Cemiplimab) will activate a patients own tumor-killing T cells to shrink pancreatic tumors. This trial will open the door to more promising immunotherapy treatment options for pancreatic cancer patients. Accelerating the Pace of Discovery at the Dedicated Lustgarten Labs: The Lustgarten Foundation is the only non-profit to fund five Dedicated Pancreatic Cancer Research Labs. These labs are united in their shared goals of increasing collaboration between world-renowned pancreatic cancer researchers, exploring promising avenues for understanding and treating pancreatic cancer and improving patient outcomes. Despite the formidable challenges of 2020 caused by the pandemic, Lustgarten researchers rallied together to continue making research progress to benefit patients. - Cold Spring Harbor Laboratory (Long Island, New York) Focusing on Personalized Medicine Dr. David Tuveson leads the Lustgarten Laboratory at Cold Spring Harbor Laboratory, designing new models of the disease and discovering novel therapeutic and diagnostic platforms to bring new options to patients more rapidly. Dr. Tuveson was the first scientist to develop a pancreatic cancer organoid a three-dimensional cell culture system which reproduces a patients tumor. This enables researchers to repeatedly test the effectiveness of different drugs to accurately predict how a patient will respond to various therapies, offering the hope of personalized cancer treatments. The labs new organoid facility will grow and test organoids for PASS-01 clinical trial participants. - Dana-Farber Cancer Institute (Boston, Massachusetts) Advancing Translational Research Under the leadership of Dr. Brian Wolpin, the Lustgarten Laboratory at Dana-Farber is a critical hub for advancing research from the laboratory to the clinic, initiating scientifically-driven clinical trials and identifying new approaches to early detection. Dr. Wolpin and his team are also analyzing pancreatic cancer subtypes to understand mechanisms of drug resistance and the genetic drivers that determine each subtype. During FY2020, Dr. Wolpin and his team made significant progress in understanding an inherited risk for pancreatic cancer. - Johns Hopkins (Baltimore, Maryland) Furthering Early Detection and Therapeutics Directed by Dr. Bert Vogelstein, the Lustgarten Laboratory at Johns Hopkins is using its expertise in early detection to discover pancreatic cancer at an earlier stage, when patients may be surgical candidates, and is developing new therapeutic approaches based on genetic alterations. - Johns Hopkins (Baltimore, Maryland) Advancing Immunology Led by Dr. Elizabeth Jaffee, this lab is working to bring novel therapies for pancreatic cancer to the clinic as quickly as possible. Building on decades of experience and expertise in the immunology of pancreatic cancer, Dr. Jaffee and her team are focusing on immune therapies and developing approaches to bring the benefits of this revolutionary approach to treating tumors to pancreatic cancer. - Massachusetts Institute of Technology (Cambridge, Massachusetts) Merging Technology and Engineering The Lustgarten Laboratory at MIT is leveraging its unparalleled expertise in cancer biology and engineering to advance pancreatic cancer research. Led by Dr. Tyler Jacks, the laboratory is studying the genetic events contributing to cancer development and examining the immune responses to the disease using molecular profiling to identify tumor mutations. Dr. Jacks and his team also are running preclinical trials in mouse model systems to see which drugs and drug combinations work best to bring about a proper immune response against pancreatic cancer. Pursuing Early Detection Techniques: - CancerSEEK Accelerates Early Detection Lustgarten-funded research at Johns Hopkins played an instrumental role in the development of an early detection blood-based test called CancerSEEK that can identify the presence of multiple cancers. A landmark study of the test, released in April 2020, showed promising results for earlier detection as part of routine medical checks, enabling potentially curative treatment that could change patient outcomes. The study found that the test more than doubled the number of cancers that were first "screen-detectedidentified undiagnosed cancers in 10 different organs (including seven with no current standard-of-care screening). - Artificial Intelligence is Key to Detecting Pancreatic Cancer Earlier Lustgarten-funded researchers at Johns Hopkins also are using artificial intelligence to detect pancreatic cancer earlier. Through their research, theyve trained computers to recognize patterns in medical images to detect pancreatic tumors on CT scans and identify tumors measuring one centimeter or less, when they may be missed by a diagnostician, so diagnosis and subsequent treatment can be started much sooner. - New CompCyst Test Can Prevent Unnecessary Surgeries The Lustgarten-dedicated laboratory at Johns Hopkins is developing a test called CompCyst, which combines clinical, radiological, genetic and protein marker information to classify pancreatic cysts and determine which ones require surgery. The Lustgarten Laboratory at Johns Hopkins is working to further develop CompCyst into a clinically approved test.
Identifying Novel Therapeutic Approaches:To ensure a robust and flourishing pipeline of potential treatments and enable collaboration, the Foundation launched a new Therapeutics-Focused Research Program, awarding grants to research aiming to: - Learn how the stroma the supportive tissue surrounding the pancreatic tumor may help protect tumors from the immune system and resist therapies. - Understand and discover how to block the inflammatory signals that can lead to pancreatic cancer and other pancreatic diseases in response to environmental causes. - Determine ways to stop tumor cell growth by blocking the abnormal metabolic pathways used by pancreatic cancer cells. - Prevent the spread or metastasis of cancer by isolating metastatic triggers in cancer cells and the stroma. Expanding Collaboration with Stand Up To Cancer: The Pancreatic Cancer Collective, a joint initiative of the Lustgarten Foundation and Stand Up To Cancer, is making groundbreaking progress in identifying new ways to treat pancreatic cancer and improving outcomes for patients. The Collective is conducting nearly 30 clinical trials led by more than 400 research investigators at approximately 70 participating institutions. During FY2020, four projects supported by the Collectives "New Therapies Challenge Grants" made it through the second round of funding, enabling researchers to take potential treatments into clinical trials and accelerate the discovery of new therapeutic options. Additionally, the Collective awarded two grants for computational approaches using artificial intelligence to mimic human reasoning and identify individuals in the general population who are at high risk for pancreatic cancer. FORM 990, PART III, LINE 4B PUBLIC EDUCATION AND INFORMATION PROGRAM $1,165,750 The Lustgarten Foundation is the largest private funder of pancreatic cancer research in the world. The Foundations mission is to cure pancreatic cancer by funding scientific and clinical research related to the diagnosis, treatment and prevention of pancreatic cancer; providing research information and clinical support services to patients, caregivers and individuals at high risk; and increasing public awareness and hope for those dealing with this disease. The Lustgarten Foundation created, printed and distributed materials to update patients, caregivers, survivors, donors, volunteers, walk and event leaders and corporate sponsors on research developments, Foundation milestones and walks/events. Materials included: - Progress & Promise newsletters - Interview with an Expert Q&A pieces - Annual report - Monthly e-newsletter - Research milestones update - Pre-packaged article for publication in community newspapers nationwide with accompanying radio public service announcement - Television public service announcement focusing on the Foundations commitment to research The Lustgarten Foundation continues to distribute its Understanding Pancreatic Cancer: A Guide for Patients & Caregivers handbook, containing information on navigating a pancreatic cancer diagnosis and treatment. The book and many of the materials noted above are accessible at www.lustgarten.org. FORM 990, PART III, LINE 4C PROFESSIONAL EDUCATION PROGRAM $246,644 Professional education focused on the Foundations senior leadership conducting high-level meetings with scientists, directors of the five dedicated laboratories and collaborating organizations as well as attending/presenting at scientific meetings for organizations including the American Association for Cancer Research (AACR) and Stand Up To Cancer. The Foundation served as a lead sponsor for the AACR Special Meeting on Pancreatic Cancer held in September 2019. The Foundation held its annual scientific meeting for the Scientific Advisory Board and select researchers in November 2019 as well. These meetings helped foster a better understanding of global developments in pancreatic cancer research and progress/trends to help shape the Foundations annual research program and long-term strategic goals. The Stand Up To Cancer Summit held in January 2020 provides an opportunity for funded researchers from the Pancreatic Cancer Collective and Foundation leadership to gather for a dynamic and inspiring conference where more than 300 top scientists come together to discuss breakthroughs and updates in cancer research. The Collective scientists make presentations to the entire group as well as presenting projects in more detail for closed session progress reports and reviews. FORM 990, PART VI, SECTION A, LINE 2 CHARLES F. DOLAN, JAMES L. DOLAN AND QUENTIN DOLAN - FAMILY AND BUSINESS RELATIONSHIP. MARCIA LUSTGARTEN, ANDREW LUSTGARTEN AND JESSICA LUSTGARTEN COURTEMANCHE FAMILY RELATIONSHIP.
FORM 990, PART VI, SECTION B, LINE 11BFORM 990 IS REVIEWED BY THE PRESIDENT FOR ACCURACY AND REASONABLENESS PRIOR TO SUBMISSION TO THE IRS. ADDITIONALLY A COMPLETE COPY OF THE FINAL RETURN IS PROVIDED TO ALL VOTING BOARD MEMBERS PRIOR TO FILING WITH THE IRS.
FORM 990, PART VI, SECTION B, LINE 12CTHE ORGANIZATION HAS A WRITTEN CONFLICT OF INTEREST POLICY. THE WRITTEN POLICY REQUIRES ANNUAL DISCLOSURES BY ALL MEMBERS OF THE BOARD OF DIRECTORS, OFFICERS, AND KEY PERSONS OF ANY INTEREST THAT COULD GIVE RISE TO CONFLICT. THE ORGANIZATION REGULARLY AND CONSISTENTLY MONITORS AND ENFORCES THE COMPLIANCE OF THE CONFLICT OF INTEREST POLICY. In the instance where a director has a conflict, they are asked by the Board Chair to recuse themselves from deliberations, decisions and the vote.
FORM 990, PART VI, SECTION B, LINE 15A & 15BCompensation for the Organization's President & CEO is reviewed and approved by the independent members of the board of directors. Compensation for other officers is reviewed by the Human Resources Department. Compensation reviews are performed with a consultant, who provides comparability data for review. Due to the COVID-19 pandemic, a compensation review did not take place in FY2020, but the Foundation is planning to conduct one in FY2021.
FORM 990, PART VI, SECTION C, LINE 19AUDITED FINANCIAL STATEMENTS ARE MADE AVAILABLE ON THE ORGANIZATION'S WEBSITE. IN ADDITION, GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND AUDITED FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.